From: The optimal sequence of radiotherapy and chemotherapy in adjuvant treatment of breast cancer
Variable | All patients [%] | Group A [%] | Group B [%] | Group C [%] | p |
---|---|---|---|---|---|
Total number | 267 | 67 | 150 | 50 | Â |
Age at diagnosis (Mean) year | 49.5 | 50 | 49 | 50.3 | 0.9 |
Menopausal status | Â | Â | Â | Â | Â |
Premenopausal | 108 [40.7] | 26 [38.8] | 62 [41.3] | 20 [40] | p > 0.5 |
perimenopausal | 48 [18] | 15 [22.4] | 25 [16.7] | 8 [16] | Â |
postmenopausal | 111 [41.3] | 26 [38.8] | 63 [42] | 22 [44] | Â |
Laterality | Â | Â | Â | Â | p > 0.5 |
Right | 116 [56.6] | 32 [47.8] | 60 [40] | 24 [48] | Â |
Left | 151 [43.4] | 35 [55.2] | 90 [60] | 26 [52] | Â |
Stage | Â | Â | Â | Â | p > 0.5 |
I | 18 [6.7] | 5 [7.5] | 9 [6] | 4 [8] | Â |
II | 181 [67.8 | 39 [58.2] | 109 [72.7] | 33 [66] | Â |
III | 68 [25.5] | 23 [34.3] | 32 [21.3] | 13 [26] | Â |
Type of surgery | Â | Â | Â | Â | p > 0.5 |
MRM | 234 [87.6] | 57 [85.1] | 131 [87.3] | 43 [86] | Â |
BCS | 33 [12.4] | 10 [14.9] | 19 [12.7] | 7 [14] | Â |
Hormonal receptor | 151 [56.6] | 41 [61.2] | 79 [52.6] | 31 [14] | p > 0.5 |
Positive | 116 [43.4] | 26 [38.8] | 71 [47.4] | 19 [12] | Â |
Negative | Â | Â | Â | Â | Â |